CHD7 regulates craniofacial cartilage development via controlling HTR2B expression.
Maximilian BreuerMaximilian RummlerJaskaran SinghSabrina MaherCharlotte ZaouterPriyanka JamadagniNicolas PilonBettina M WillieShunmoogum A PattenPublished in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2024)
Mutations in the Chromodomain helicase DNA-binding protein 7 - coding gene (CHD7) cause CHARGE syndrome (CS). Although craniofacial and skeletal abnormalities are major features of CS patients, the role of CHD7 in bone and cartilage development remain largely unexplored. Here, using a zebrafish (Danio rerio) CS model, we show that chd7-/- larvae display abnormal craniofacial cartilage development and spinal deformities. The craniofacial and spine defects are accompanied by a marked reduction of bone mineralization. At the molecular level, we show that these phenotypes are associated with significant reduction in the expression levels of osteoblast differentiation markers. Additionally, we detected a marked depletion of collagen 2α1 in the cartilage of craniofacial regions and vertebrae, along with significantly reduced number of chondrocytes. Chondrogenesis defects are at least in part due to downregulation of htr2b, which we found to be also dysregulated in human cells derived from an individual with CHD7 mutation-positive CS. Overall, this study thus unveils an essential role for CHD7 in cartilage and bone development, with potential clinical relevance for the craniofacial defects associated with CS.
Keyphrases
- binding protein
- extracellular matrix
- poor prognosis
- bone mineral density
- end stage renal disease
- ejection fraction
- chronic kidney disease
- single molecule
- spinal cord injury
- newly diagnosed
- long non coding rna
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- zika virus
- patient reported
- genome wide analysis